Gryphon Financial Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Sell
1,219
-20
-2% -$4.16K 0.03% 310
2026
Q1
$262K Buy
1,239
+53
+4% +$11.4K 0.03% 309
2025
Q4
$244K Sell
1,186
-133
-10% -$25K 0.03% 305
2025
Q3
$207K Buy
1,319
+78
+6% +$12K 0.02% 313
2025
Q2
$208K Buy
+1,241
New +$184K 0.03% 297
2024
Q1
Sell
-2,446
Closed -$202K 256
2023
Q4
$202K Buy
+2,446
New +$243K 0.04% 224
2018
Q3
Sell
-1,242
Closed -$60K 258
2018
Q2
$60K Sell
1,242
-10,007
-89% -$567K 0.03% 195
2018
Q1
$705K Buy
11,249
+9,924
+749% +$681K 0.36% 28
2017
Q4
$81K Buy
+1,325
New +$81.9K 0.05% 166

Other funds holding CAH

Gryphon Financial Partners's CAH Position: Q2 2026 in Review

Gryphon Financial Partners reduced its Cardinal Health (CAH) stake by 1.6% in Q2 2026, selling an estimated $4.16K and leaving 1,219 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #310.

Gryphon Financial Partners first reported a position in CAH in Q4 2017 and has held it in 9 quarters since. The position peaked at $705K in Q1 2018. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Gryphon Financial Partners held 1,219 shares of Cardinal Health worth $290K as of Q2 2026.
  • Gryphon Financial Partners sold 20 Cardinal Health shares in Q2 2026, an estimated $4.16K.
  • Cardinal Health made up 0.03% of Gryphon Financial Partners's portfolio in Q2 2026, its #310 holding.
  • Gryphon Financial Partners first reported a position in Cardinal Health in Q4 2017 and has held it in 9 quarters since.
  • Gryphon Financial Partners's Cardinal Health position peaked at $705K in Q1 2018.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Gryphon Financial Partners's 13F filing for Q2 2026, filed 5 Aug 2026.